CN104507905A - 制备18F-Fluciclovine - Google Patents

制备18F-Fluciclovine Download PDF

Info

Publication number
CN104507905A
CN104507905A CN201380041838.9A CN201380041838A CN104507905A CN 104507905 A CN104507905 A CN 104507905A CN 201380041838 A CN201380041838 A CN 201380041838A CN 104507905 A CN104507905 A CN 104507905A
Authority
CN
China
Prior art keywords
compound
formula
solid phase
facbc
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380041838.9A
Other languages
English (en)
Chinese (zh)
Inventor
A.斯瓦德贝格
O.赖因
R.斯米茨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to CN201810568649.1A priority Critical patent/CN108997169A/zh
Publication of CN104507905A publication Critical patent/CN104507905A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J16/00—Chemical processes in general for reacting liquids with non- particulate solids, e.g. sheet material; Apparatus specially adapted therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/245—Stationary reactors without moving elements inside placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/248—Reactors comprising multiple separated flow channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/24—Stationary reactors without moving elements inside
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/24—Stationary reactors without moving elements inside
    • B01J2219/2401—Reactors comprising multiple separate flow channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
CN201380041838.9A 2012-08-09 2013-08-07 制备18F-Fluciclovine Pending CN104507905A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810568649.1A CN108997169A (zh) 2012-08-09 2013-08-07 制备18F-Fluciclovine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1214220.4A GB201214220D0 (en) 2012-08-09 2012-08-09 Radiosynthesis
GB1214220.4 2012-08-09
PCT/EP2013/066570 WO2014023775A1 (en) 2012-08-09 2013-08-07 Preparation of 18f-fluciclovine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201810568649.1A Division CN108997169A (zh) 2012-08-09 2013-08-07 制备18F-Fluciclovine

Publications (1)

Publication Number Publication Date
CN104507905A true CN104507905A (zh) 2015-04-08

Family

ID=46935146

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380041838.9A Pending CN104507905A (zh) 2012-08-09 2013-08-07 制备18F-Fluciclovine
CN201810568649.1A Pending CN108997169A (zh) 2012-08-09 2013-08-07 制备18F-Fluciclovine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201810568649.1A Pending CN108997169A (zh) 2012-08-09 2013-08-07 制备18F-Fluciclovine

Country Status (14)

Country Link
US (2) US9359288B2 (cg-RX-API-DMAC7.html)
EP (1) EP2885271A1 (cg-RX-API-DMAC7.html)
JP (1) JP6574379B2 (cg-RX-API-DMAC7.html)
KR (1) KR102109225B1 (cg-RX-API-DMAC7.html)
CN (2) CN104507905A (cg-RX-API-DMAC7.html)
AU (1) AU2013301499B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015002077A2 (cg-RX-API-DMAC7.html)
CA (1) CA2878636A1 (cg-RX-API-DMAC7.html)
GB (2) GB201214220D0 (cg-RX-API-DMAC7.html)
IL (1) IL236312A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN10962A (cg-RX-API-DMAC7.html)
MX (2) MX388930B (cg-RX-API-DMAC7.html)
RU (1) RU2640805C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014023775A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106770883A (zh) * 2017-01-03 2017-05-31 原子高科股份有限公司 一种氟[18f]化钠注射液放化纯的薄层色谱分析方法
CN110290868A (zh) * 2016-12-21 2019-09-27 通用电气健康护理有限公司 固相调节

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130132892A (ko) * 2010-12-29 2013-12-05 지이 헬쓰케어 리미티드 용리제 용액
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) * 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB201214220D0 (en) 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis
US20180170822A1 (en) * 2015-06-05 2018-06-21 Nihon Medi-Physics Co., Ltd. Device and method for producing radioactively labeled compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101443307A (zh) * 2006-05-11 2009-05-27 日本医事物理股份有限公司 放射性氟标记有机化合物的制备方法
CN101573330A (zh) * 2006-12-27 2009-11-04 日本医事物理股份有限公司 放射性卤素标记的有机化合物的前体化合物的制备方法
WO2012089594A1 (en) * 2010-12-29 2012-07-05 Ge Healthcare Limited Eluent solution

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
EP2119458B9 (en) 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
US8269035B2 (en) * 2007-12-19 2012-09-18 Nihon Medi-Physics Co., Ltd. Process for production of radioactive-fluorine-labeled organic compound
CA2785179C (en) 2009-10-08 2018-06-05 Ge Healthcare Limited Purification method
CN103221382B (zh) 2010-11-29 2016-06-01 通用电气健康护理有限公司 制备pet前体
GB201021523D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Process simplification for precursor compound
MX2013007186A (es) 2010-12-20 2013-07-12 Ge Healthcare Ltd Purificacion de compuesto precursor mediante cristalizacion.
GB201021530D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Purification of precursor compound by crystallisation
GB201214220D0 (en) 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101443307A (zh) * 2006-05-11 2009-05-27 日本医事物理股份有限公司 放射性氟标记有机化合物的制备方法
CN101573330A (zh) * 2006-12-27 2009-11-04 日本医事物理股份有限公司 放射性卤素标记的有机化合物的前体化合物的制备方法
WO2012089594A1 (en) * 2010-12-29 2012-07-05 Ge Healthcare Limited Eluent solution

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110290868A (zh) * 2016-12-21 2019-09-27 通用电气健康护理有限公司 固相调节
US12208372B2 (en) 2016-12-21 2025-01-28 Ge Healthcare Limited Solid phase conditioning
CN106770883A (zh) * 2017-01-03 2017-05-31 原子高科股份有限公司 一种氟[18f]化钠注射液放化纯的薄层色谱分析方法
CN106770883B (zh) * 2017-01-03 2019-01-29 原子高科股份有限公司 一种氟[18f]化钠注射液放化纯的薄层色谱分析方法

Also Published As

Publication number Publication date
BR112015002077A2 (pt) 2017-07-04
MX2015001724A (es) 2015-04-14
AU2013301499A1 (en) 2015-01-22
KR20150039204A (ko) 2015-04-09
MX368668B (es) 2019-10-10
RU2640805C2 (ru) 2018-01-12
JP2015530985A (ja) 2015-10-29
EP2885271A1 (en) 2015-06-24
GB2519026B (en) 2019-09-04
US20150232415A1 (en) 2015-08-20
IN2014DN10962A (cg-RX-API-DMAC7.html) 2015-09-18
MX2019012139A (es) 2019-12-09
WO2014023775A1 (en) 2014-02-13
US10023525B2 (en) 2018-07-17
GB2519026A (en) 2015-04-08
KR102109225B1 (ko) 2020-05-11
GB201214220D0 (en) 2012-09-19
US9359288B2 (en) 2016-06-07
JP6574379B2 (ja) 2019-09-11
US20160355460A1 (en) 2016-12-08
RU2015101998A (ru) 2016-09-27
CA2878636A1 (en) 2014-02-13
AU2013301499B2 (en) 2017-08-31
IL236312A0 (en) 2015-02-26
MX388930B (es) 2025-03-20
GB201501016D0 (en) 2015-03-04
CN108997169A (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
EP3766522B1 (en) Automated method for the preparation of 18f-fluciclovine compositions
US10023525B2 (en) Preparation of 18F-fluciclovine
JP2022136074A (ja) 新規製剤及び合成方法
EP2793954B1 (en) 18f-fluciclovine compositions in citrate buffers
CA2908029C (en) Radiolabelling process
NZ624250A (en) 18f-fluciclovine compositions in citrate buffers
HK1234386B (en) Novel formulation and method of synthesis
BR112015024344B1 (pt) Método para obter uma composição
GB2561122A (en) 18F - Fluciclovine compositions in citrate buffers

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150408